ClinVar Miner

Submissions for variant NM_012233.3(RAB3GAP1):c.748+1G>A

dbSNP: rs587776651
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000578621 SCV000680759 pathogenic not provided 2017-11-28 criteria provided, single submitter clinical testing The c.748+1G>A variant in the RAB3GAP1 gene has been reported previously in association with Warburg Micro syndrome, and is considered a founder mutation in the Turkish population (Handley et al., 2013). This splice site variant destroys the canonical splice donor site of intron 8. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.748+1G>A variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.748+1G>A as a pathogenic variant.
Labcorp Genetics (formerly Invitae), Labcorp RCV000578621 SCV000932155 pathogenic not provided 2023-12-05 criteria provided, single submitter clinical testing This sequence change affects a donor splice site in intron 8 of the RAB3GAP1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RAB3GAP1 are known to be pathogenic (PMID: 23420520). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Warburg Micro syndrome (PMID: 15696165, 23420520, 26852512). ClinVar contains an entry for this variant (Variation ID: 7058). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin RCV000007474 SCV002574809 pathogenic Warburg micro syndrome 1 2022-09-22 criteria provided, single submitter clinical testing
Ambry Genetics RCV002512875 SCV003620053 pathogenic Inborn genetic diseases 2022-06-17 criteria provided, single submitter clinical testing The c.748+1G>A intronic variant results from a G to A substitution one nucleotide(s) after coding exon 8 of the RAB3GAP1 gene. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This mutation has been reported in the homozygous state is several Turkish individuals with Warburg micro syndrome (Aligianis, 2005; Morris-Rosendahl, 2010; Handley, 2012; Handley, 2013; Tasdemir, 2015). Based on the available evidence, this alteration is classified as pathogenic.
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV000007474 SCV003922350 pathogenic Warburg micro syndrome 1 2023-05-02 criteria provided, single submitter curation The homozygous c.748+1G>A variant in RAB3GAP1 was identified by our study in one individual with congenital cataracts, corpus callosum atrophy, spastic tetraparesis, and neurodevelopmental delay. The c.748+1G>A variant in RAB3GAP1 has been previously reported in 10 individuals with Warburg micro syndrome 1 (PMID: 31319225, PMID: 23420520, PMID: 26852512, PMID: 17351351, PMID: 15696165), but has been identified in 0.0008% (1/125568) of chromosomes by TopMed Bravo (https://bravo.sph.umich.edu/, dbSNP ID: rs587776651). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 7058) and has been interpreted as pathogenic by GeneDx, Erasmus Medical Center, Invitae, Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, and OMIM. The 10 affected individuals previously reported were homozygotes (PMID: 31319225, PMID: 23420520, PMID: 26852512, PMID: 17351351, PMID: 15696165), which increases the likelihood that the c.748+1G>A variant is pathogenic. This variant is located in the 5’ splice region. Computational tools do suggest an impact to splicing. However, this information is not predictive enough to determine pathogenicity. Loss of function of the RAB3GAP1 gene is an established disease mechanism in autosomal recessive Warburg micro syndrome 1. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Warburg micro syndrome 1. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3 (Richards 2015).
OMIM RCV000007474 SCV000027674 pathogenic Warburg micro syndrome 1 2013-05-01 no assertion criteria provided literature only
GeneReviews RCV000007474 SCV000778354 not provided Warburg micro syndrome 1 no assertion provided literature only
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000578621 SCV001953631 pathogenic not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000578621 SCV001975369 pathogenic not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.